As of April 17, 2024, Aurinia Pharmaceuticals Inc had a $723.1 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Aurinia ...

GENEVA - A significant shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: NASDAQ:AUPH), Lucien Selce, who holds approximately 2.2% of the company's outstanding shares, has publicly voiced ...

Aurinia Pharmaceuticals is using Lupus Awareness Month to get its message about screening and treatment to a wider audience. The drugmaker will play a part in meetings across May, including an ...

(1) Free cash flow is a non-GAAP financial measure and is calculated as net cash provided by or used in operating activities reduced by purchases of property and equipment.

ROCKVILLE, Md. & EDMONTON, Alberta, May 14, 2024--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced the presentation of results from an updated cost-effective ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GENEVA - A significant shareholder of Aurinia Pharmaceuticals Inc. (NASDAQ: NASDAQ:AUPH), Lucien Selce, who holds approximately 2.2% of the company's outstanding shares, has publicly voiced concerns ...

ROCKVILLE, Md. & EDMONTON, Alberta, May 14, 2024--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced the presentation of results from an updated cost-effective ...

EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $10.7 million in its first quarter. On a per-share basis, the Edmonton ...